These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15726418)

  • 1. BRCA1 variants in a family study of African-American and Latina women.
    McKean-Cowdin R; Spencer Feigelson H; Xia LY; Pearce CL; Thomas DC; Stram DO; Henderson BE
    Hum Genet; 2005 May; 116(6):497-506. PubMed ID: 15726418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.
    Newman B; Mu H; Butler LM; Millikan RC; Moorman PG; King MC
    JAMA; 1998 Mar; 279(12):915-21. PubMed ID: 9544765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
    Nanda R; Schumm LP; Cummings S; Fackenthal JD; Sveen L; Ademuyiwa F; Cobleigh M; Esserman L; Lindor NM; Neuhausen SL; Olopade OI
    JAMA; 2005 Oct; 294(15):1925-33. PubMed ID: 16234499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families.
    Weitzel JN; Lagos VI; Herzog JS; Judkins T; Hendrickson B; Ho JS; Ricker CN; Lowstuter KJ; Blazer KR; Tomlinson G; Scholl T
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1615-20. PubMed ID: 17646271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort.
    Bretsky P; Haiman CA; Gilad S; Yahalom J; Grossman A; Paglin S; Van Den Berg D; Kolonel LN; Skaliter R; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):733-8. PubMed ID: 12917204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline BRCA Mutation Rates in Latina Women Presenting for Gynecologic Oncology Care.
    Hong L; Gonzalez R; Unternaehrer J; Ioffe Y
    Gynecol Obstet Invest; 2020; 85(3):214-221. PubMed ID: 32203957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women.
    Haffty BG; Silber A; Matloff E; Chung J; Lannin D
    J Med Genet; 2006 Feb; 43(2):133-7. PubMed ID: 15983021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of BRCA1 gene in African-American patients with breast cancer.
    Shen D; Wu Y; Subbarao M; Bhat H; Chillar R; Vadgama JV
    J Natl Med Assoc; 2000 Jan; 92(1):29-35. PubMed ID: 10800284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.
    Pal T; Permuth-Wey J; Holtje T; Sutphen R
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1794-9. PubMed ID: 15533909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
    John EM; Miron A; Gong G; Phipps AI; Felberg A; Li FP; West DW; Whittemore AS
    JAMA; 2007 Dec; 298(24):2869-76. PubMed ID: 18159056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.
    Jackson SA; Davis AA; Li J; Yi N; McCormick SR; Grant C; Fallen T; Crawford B; Loranger K; Litton J; Arun B; Vande Wydeven K; Sidani A; Farmer K; Sanders M; Hoskins K; Nussbaum R; Esserman L; Garber JE; Kaklamani VG;
    Cancer; 2014 May; 120(10):1557-64. PubMed ID: 24522996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer.
    Halbert CH; Kessler L; Stopfer JE; Domchek S; Wileyto EP
    Genet Med; 2006 Sep; 8(9):576-82. PubMed ID: 16980814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.
    Hirsch AE; Atencio DP; Rosenstein BS
    Breast Cancer Res Treat; 2008 Jan; 107(1):139-44. PubMed ID: 17333338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
    Gao Q; Tomlinson G; Das S; Cummings S; Sveen L; Fackenthal J; Schumm P; Olopade OI
    Hum Genet; 2000 Aug; 107(2):186-91. PubMed ID: 11030417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer.
    Kessler L; Domchek S; Stopfer J; Halbert CH
    Community Genet; 2008; 11(4):193-200. PubMed ID: 18417966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.
    Bell DW; Kim SH; Godwin AK; Schiripo TA; Harris PL; Haserlat SM; Wahrer DC; Haiman CA; Daly MB; Niendorf KB; Smith MR; Sgroi DC; Garber JE; Olopade OI; Le Marchand L; Henderson BE; Altshuler D; Haber DA; Freedman ML
    Int J Cancer; 2007 Dec; 121(12):2661-7. PubMed ID: 17721994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
    Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
    Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
    Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.